Tickerplace logo

Tickerplace

Spyre Therapeutics, Inc. logo

SYRESpyre Therapeutics, Inc.

SYRE Stock Price, Valuation & Chart | Spyre Therapeutics, Inc.

Compare
$79.900-0.20 (-0.25%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

SYRE Historical price chart

SYRE Key Stats

Market Capitalization7.37B
PE Ratio-40.97
EPS-1.95
Trading Volume1.27M
Today's High/Low80.52/78.09
Dividend Yield0.00
52 Week High/Low110.18/21.14
Shares Outstanding92.29M
SYRE Financial Statement
SYRE Analyst ratings
SYRE Analysis & performance metrics

SYRE Company profile

Spyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops…

SYRE Management team

Management
Eric McIntyre
Vice President of Finance & Investor Relations
Melissa Cooper
Senior Vice President of People
Scott L. BurrowsCFO
Chief Financial Officer
Justin LaFountaine Ph.D.
Senior Vice President of Corporate Development
Sheldon Sloan M.B.E., M.D.
Chief Medical Officer
Heidy Abreu King-Jones J.D., L.L.M.
Chief Legal Officer & Corporate Secretary
James Myers
Vice President of Quality & Compliance
Brian Connolly
Chief Technical Officer
Total 8 executives

SYRE Frequently asked questions

What is Spyre Therapeutics, Inc. (SYRE) Stock Price?

Current stock price of Spyre Therapeutics, Inc. (SYRE) stock is $79.900. The stock price is -0.25% lower in the session. The intraday range can be seen from this page. Volume of Spyre Therapeutics, Inc. (SYRE) stock is 1.27M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Spyre Therapeutics, Inc. (SYRE) stock price going up or down today?

The stock price of Spyre Therapeutics, Inc. (SYRE) can change with earnings, company news, and overall market sentiment. Spyre Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Spyre Therapeutics, Inc. stock expensive at its current price?

Whether Spyre Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SYRE on this page is -40.97. EPS on this page is -1.95. Compare those figures with peers and growth expectations before deciding if the current Spyre Therapeutics, Inc. price is justified.

How has the stock price of Spyre Therapeutics, Inc. (SYRE) performed historically?

Historical performance for Spyre Therapeutics, Inc. (SYRE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SYRE reacted to past earnings and market events.

Should I buy Spyre Therapeutics, Inc. (SYRE) stock, at this price?

Buying Spyre Therapeutics, Inc. (SYRE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.